Vital Strategic Research Institute (VSRI) is an independent research firm with expertise in design and conducts evidence based clinical trials, real world clinical research, comparative effectiveness research, health technology assessment, health information management, medical education and publication. We conduct global research including China.
Vital Strategic collaborates with hospitals and physicians on clinical research, registry, health information management concerning all disease areas, aiming to improving chronic disease management and improving patient care quality.
Vital Strategic partners with pharmaceutical, medical device, and biotechnology companies for better defining unmet needs, better assessing clinical outcomes, better determine cost effectiveness, better achieving evidence-driven market access.
PATIENTS & CAREGIVERS
Vital Strategic helps patients and caregivers better understand disease preventive care, treatment options, treatment outcomes, home monitoring, risk prediction, as well as health care values, and personalized medicine.
Shanghai Hua Si Tai Medical Consultation Company Limited (Shanghai) profit and loss 2015 – 2016.
Highlights show a significant increase in profits with what execs believe to be a sustainable trend toward assertive growth for 2017 and beyond.
The Company attributes Shanghai’s turnaround to cost cutting and improved efficiency, as it desired to enter the U.S. public markets.
Our goal for collaboration and partnership is to enhance scientific and commercial values of medical advancement. We view all partners and collaborators as our extended colleagues, whether they are medical corporations with worldwide operations or medical research institutions and health organizations with commitments to improve healthcare
policy and develop new healthcare solutions.